Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Concert Pharmaceutic
(NQ:
CNCE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Concert Pharmaceutic
< Previous
1
2
Next >
Concert Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update
November 09, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals Announces $65 Million Financing
November 04, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals to Report Third Quarter 2021 Results on November 9, 2021
November 02, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals Completes Enrollment in THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata
October 25, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
September 03, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Landmarks and Bridges Will Illuminate Blue Throughout the Month of September for Alopecia Areata Awareness Month
August 31, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals Reports Second Quarter 2021 Financial Results
August 05, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals to Report Second Quarter 2021 Results on August 5, 2021
July 29, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals Presents Update on CTP-543 Long-Term Extension Study in Alopecia Areata During 2nd JAK Inhibitors Drug Development Summit
July 01, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals Initiates THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata
May 27, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
May 26, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals Announces Sale of VX-561 Milestones to Vertex for $32 Million
May 17, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals Reports First Quarter 2021 Financial Results
May 04, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
Concert Pharmaceuticals to Report First Quarter 2021 Results on May 4, 2021
April 27, 2021
From
Concert Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.